0.63
-0.0385(-5.78%)
Currency In USD
| Previous Close | 0.67 |
| Open | 0.63 |
| Day High | 0.66 |
| Day Low | 0.63 |
| 52-Week High | 2.95 |
| 52-Week Low | 0.61 |
| Volume | 230,868 |
| Average Volume | 813,718 |
| Market Cap | 123.49M |
| PE | -3.3 |
| EPS | -0.19 |
| Moving Average 50 Days | 0.81 |
| Moving Average 200 Days | 1.1 |
| Change | -0.04 |
If you invested $1000 in Tevogen Bio Holdings Inc. (TVGN) since IPO date, it would be worth $63.16 as of October 27, 2025 at a share price of $0.628. Whereas If you bought $1000 worth of Tevogen Bio Holdings Inc. (TVGN) shares 2 years ago, it would be worth $57.76 as of October 27, 2025 at a share price of $0.628.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest
GlobeNewswire Inc.
Oct 15, 2025 7:50 PM GMT
Company intends to collaborate with government initiatives, Long COVID patient organizations, and major healthcare providers to expedite development of TVGN 489In recognition of the high volume of patient inquiries, Tevogen has established a dedicate
Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion
GlobeNewswire Inc.
Sep 25, 2025 12:30 PM GMT
Beta version of PredicTcell™ expands training dataset to ~1.4 million and total dataset to over 6.7 billion records.Potential future T cell therapies could reliably bind to their target nearly every time, dramatically raising the probability of succe
Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID
GlobeNewswire Inc.
Sep 23, 2025 12:30 PM GMT
WARREN, N.J., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlights emerging scientific evidence linking persistent viral reservoirs to Long COVID, and emphasizes the potential of it